Delfi Diagnostics is developing high-performing, accessible blood tests for early detection of cancer to help people live longer, healthier lives.

Biotechnology

Education

Delfi Diagnostics

The Palo Alto office focuses on R&D, legal, finance, and operations, driving innovation in biotech and technology sectors.

Palo Alto

Delfi Diagnostics' headquarters in Baltimore, MD, United States

Victor Velculescu

Peter B.

Michaela Hart

Amoolya Singh

Tom Russo

Lee-Ann Smith-Freeman

Ally Dashner

Peter B. Bach

Merdidth Halks Miller

Justin Kao

Alberto Gutierrez

Mike Dybbs

Julia Sidenius Johansen

Giovanni Parmigiani

Kwok-Kin Wong

Liz Homans

Jacob Van Naarden

Lee Newcomer

Greg Yap

Rishi Gupta

Anil Vachani

The Data Science & Bioinformatics team at Delfi Diagnostics leverages advanced computational techniques and statistical analysis to analyze complex biological data, driving the development of innovative blood tests for early cancer detection. This multidisciplinary team collaborates on data integration, assay development, and clinical validation, ensuring the precision and reliability of diagnostic solutions to enhance patient care and outcomes.

Data Science & Bioinformatics

The Engineering & Technology team at Delfi Diagnostics is responsible for designing and developing sophisticated software systems that support the company's innovative blood tests for cancer detection. This multidisciplinary group focuses on ensuring software quality, regulatory compliance, and secure IT operations, while also enhancing data solutions and automation processes for efficient product delivery. Their collaborative efforts drive the technological advancements critical to optimizing diagnostics and improving patient outcomes.

Engineering & Technology

This department provides strategic oversight and direction for the organization.

Executive Leadership

The Leadership Team at Delfi Diagnostics is responsible for steering the company's strategic vision and overseeing the development of innovative blood tests for early cancer detection. Composed of experts in technology development, clinical operations, data science, regulatory affairs, and market access, this team collaborates to integrate scientific advancements with business strategies, ensuring that Delfi’s solutions are not only effective but also accessible to patients. Their collective expertise drives growth, fosters innovation, and positions Delfi Diagnostics as a leader in the diagnostic space.

Leadership Team

This department provides expert guidance and strategic advice to support decision-making and operational effectiveness.

Advisory Services

The Clinical Development & Regulatory Affairs team at Delfi Diagnostics is responsible for designing and overseeing clinical trials to evaluate the safety and efficacy of the company's blood tests for early cancer detection. They ensure compliance with regulatory requirements, manage clinical data, and collaborate with medical professionals to translate clinical insights into strategic development plans, ultimately contributing to the delivery of innovative diagnostics that improve patient outcomes.

Delfi Diagnostics

Org chart

Board & advisors

Teams

Data Science & Bioinformatics

Engineering & Technology

Executive Leadership

Leadership Team

Advisory Services

Clinical Development & Regulatory Affairs

Offices

Delfi Diagnostics

Org chart

Board & advisors

Teams

Data Science & Bioinformatics

Engineering & Technology

Executive Leadership

Leadership Team

Advisory Services

Clinical Development & Regulatory Affairs

Offices

Related companies